Top Gainers and Losers on January 8: ONGC and ITC Shine, Apollo Hospitals Dips
On January 8, 2025, the stock market exhibited remarkable resilience.
The BSE Sensex recovered approximately 650 points from its intraday low, ultimately closing 58 points lower, or 0.07%, at 78,141.06. The Sensex fluctuated between 77,486.79 and 78,319.45 during the session. Similarly, the NSE Nifty50 fell 19 points, or 0.08%, to settle at 23,688.95, after trading within a range of 23,496.15 to 23,751.85.
Top Gainers of the Day
Symbol | Open | High | Low | LTP | %chng |
---|---|---|---|---|---|
ONGC | 266.45 | 273.5 | 265.75 | 271.5 | 3.04 |
ITC | 443.00 | 452.05 | 437.10 | 449.65 | 1.94 |
ASIANPAINT | 2,287.05 | 2,338.00 | 2,272.70 | 2,336.50 | 1.91 |
DRREDDY | 1,369.50 | 1,405.90 | 1,358.00 | 1,375.00 | 1.74 |
TCS | 4,034.90 | 4,126.00 | 4,017.75 | 4,095.05 | 1.66 |
Oil & Natural Gas Corporation gained 3.04%, closing at ₹271.50 after hitting a high of ₹273.50.
ITC rose by 1.94%, finishing at ₹449.65, with an intraday high of ₹452.05.
Asian Paints saw a 1.91% uptick, closing at ₹2,336.50.
Dr Reddy’s gained 1.74%, ending the day at ₹1,375.00.
TCS increased by 1.66%, closing at ₹4,095.05.
Top Losers of the Day
Symbol | Open | High | Low | LTP | %chng |
---|---|---|---|---|---|
APOLLOHOSP | 7,448.75 | 7,460.00 | 7,131.00 | 7,135.05 | -4.06 |
TRENT | 6,869.55 | 6,873.50 | 6,590.35 | 6,684.95 | -2.75 |
ULTRACEMCO | 11,618.55 | 11,629.95 | 11,370.00 | 11,370.00 | -2.14 |
SHRIRAMFIN | 2,970.00 | 2,970.00 | 2,840.85 | 2,899.95 | -1.98 |
BAJAJ-AUTO | 8,776.00 | 8,830.95 | 8,612.00 | 8,644.00 | -1.89 |
Apollo Hospitals fell 4.06%, closing at ₹7,135.05 after an intraday low of ₹7,131.00.
Trent declined 2.75%, ending the session at ₹6,684.95.
UltraTech Cement dipped by 2.14%, closing at ₹11,370.00.
Shriram Finance dropped 1.98%, finishing at ₹2,899.95.
Bajaj Auto slid 1.89%, closing at ₹8,644.00.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.